SkinBioTherapeutics Plc (SBTX.L) LSE

16.63

-0.125(-0.75%)

Updated at December 04 04:09PM

Currency In GBp

Valuation

Market Cap16.77M
Enterprise Value16.78M
P/E Ratio-14.4
PEG Ratio-0.76
Price/Sales Ratio16.06
Price/Book Ratio8.26
Enterprise/Revenue15.98
Enterprise/EBITDA-18.8

Fiscal Year

Fiscal YearJune 30, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-0.96
Operating Margin-0.95

Management Effectiveness

Return On Assets-0.35
Return On Equity-0.69

Income Statement

Revenue1.21M
Revenue/Share0.01
Gross Profit683,038
EBITDA-2.72M
Net Income-2.88M
Diluted EPS-0.02

Balance Sheet

Total Cash1.24M
Total Cash/Share0.01
Total Debt1.03M
Total Debt/Equity0.23
Current Ratio1.79
Book Value Per Share0.02

Price History

52-Week Change-6.34
52-Week High27.5
52-Week Low13.72
Moving Average 50 Days15.64
Moving Average 200 Days17.91

Statistics

Average Volume880,836
Shares Outstanding258.78M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A